A5076040758- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Sphingolipid Metabolism and Signaling
- Lipid Membrane Structure and Behavior
- Monoclonal and Polyclonal Antibodies Research
- Chronic Lymphocytic Leukemia Research
- Immunodeficiency and Autoimmune Disorders
- CAR-T cell therapy research
- Blood groups and transfusion
- Immune cells in cancer
- Cancer Immunotherapy and Biomarkers
- Lymphoma Diagnosis and Treatment
- Dental Erosion and Treatment
- Angiogenesis and VEGF in Cancer
- Transplantation: Methods and Outcomes
- Erythrocyte Function and Pathophysiology
- vaccines and immunoinformatics approaches
- ATP Synthase and ATPases Research
- Atherosclerosis and Cardiovascular Diseases
- Caveolin-1 and cellular processes
- Biosimilars and Bioanalytical Methods
- Autoimmune and Inflammatory Disorders Research
- Environmental and biological studies
- Pain Management and Treatment
Centre Hospitalier Régional et Universitaire de Nancy
2023
Centre Hospitalier Universitaire de Toulouse
2015-2021
Institut universitaire du cancer de Toulouse Oncopole
2017-2021
Centre de Recherche en Cancérologie de Toulouse
2017-2021
Inserm
2017-2021
Centre National de la Recherche Scientifique
2021
Université Toulouse III - Paul Sabatier
2014-2019
La Ligue Contre le Cancer
2017
ABSTRACT The novel allele HLA‐DQA1*02:39 differs from HLA‐DQA1*02:01:01:01 by one non‐synonymous nucleotide substitution in exon 2.
ABSTRACT The novel HLA‐DRB1*07:159 allele differs from HLA‐DRB1*07:01:01:01 by one non‐synonymous nucleotide substitution in exon 2.
The novel allele HLA-DQA1*05:89 differs from HLA-DQA1*05:05:01:01 by one non-synonymous nucleotide substitution in exon 2.
The data presented in this paper are reference ranges for frequencies of thirty-eight subpopulations T, B and NK lymphocytes, established from a cohort 253 healthy blood donors aged 19 to 67. When relevant, the influence age or sex was taken into account calculate these values. This article is related research entitled "Influence age, HCMV-serostatus on lymphocyte adults" (Apoil et al., 2017) [1]. Immunophenotyping obtained each individual made publicly available extended analyses.
The novel allele HLA‐DRB1*03:210 differs from HLA‐DRB1*03:01:01:01 by one non‐synonymous nucleotide substitution in exon 3.
The novel allele HLA‐C*07:02:147 differs from HLA‐C*07:02:01:01 by one synonymous nucleotide substitution in exon 2.
The novel allele HLA‐B*44:48:02 differs from HLA‐B*44:48:01 by one synonymous nucleotide substitution in exon 3.
The novel allele HLA‐A*36:14 differs from HLA‐A*36:01:01:01 by one non‐synonymous nucleotide substitution in exon 4.
The novel allele HLA‐DPB1*1467:01 differs from HLA‐DPB1*09:01:01:01 by one non‐synonymous nucleotide substitution in exon 2.
The novel allele HLA‐A*30:01:23 differs from HLA‐A*30:01:01:01 by one synonymous nucleotide substitution in exon 2.
The novel allele HLA‐DRB1*11:323 differs from HLA‐DRB1*11:01:02:01 by one non‐synonymous nucleotide substitution in exon 2.
RATIONALE: There is an unmet need to improve the description of state T-cell exhaustion in patients with sepsis, its reproducibility and correlation outcomes before including immunotherapy (like recombinant interleukin-7 or immune checkpoint inhibitors) therapeutic armamentarium against sepsis. DESIGN: Observational prospective study. SETTING: Two ICUs a teaching hospital (France). PATIENTS: Eighty sepsis admitted ICU. INTERVENTIONS: Quantification CD4 + CD8 at days 1 3. markers (programmed...